Immunogenicity and Safety of a Newly Developed Live Attenuated Varicella Vaccine in Healthy Children: A Multi-National, Randomized, Double-Blinded, Active-Controlled, Phase 3 Study

Korean manufacturers have developed a new varicella vaccine, NBP608. This phase 3, randomized, double-blind, multicenter study aimed to compare the immunogenicity and safety of NBP608 in healthy children to those of Varivax(TM) (control). Children aged 12 months to 12 years were randomized in a rati...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Ui Yoon, Kim, Ki Hwan, Cho, Hye-Kyung, Kim, Dong Ho, Ma, Sang Hyuk, Choi, Young Youn, Kim, Chun Soo, Capeding, Maria Rosario, Kobashi, Ilya Angelica Rochin, Kim, Hun, Ryu, Ji Hwa, Lee, Su Jeen, Park, Ho Keun, Kim, Jong-Hyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10537027/
https://www.ncbi.nlm.nih.gov/pubmed/37766093
http://dx.doi.org/10.3390/vaccines11091416

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10537027/
https://www.ncbi.nlm.nih.gov/pubmed/37766093
http://dx.doi.org/10.3390/vaccines11091416

Ejemplares similares